Hobbs; Douglas Walsh

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hobbs; Douglas Walsh.The latest application filed is for "novel pyrazolopyrimidines as cyclin dependent kinase inhibitors".

Company Profile

0.7.7

Hobbs; Douglas Walsh - Yardley PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors Grant 8,673,924 - Guzi , et al. March 18, 2	2014-03-18
N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,807,683 - Guzi , et al. October 5, 2	2010-10-05
Bicyclic compounds as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders Grant 7,550,467 - Guo , et al. June 23, 2	2009-06-23
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20080050384 - Guzi; Timothy J. ; et al.	2008-02-28
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20070054906 - Guzi; Timothy J. ; et al.	2007-03-08
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20070054925 - Guzi; Timothy J. ; et al.	2007-03-08
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20070037824 - Guzi; Timothy J. ; et al.	2007-02-15
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,161,003 - Guzi , et al. January 9, 2	2007-01-09
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,119,200 - Guzi , et al. October 10, 2	2006-10-10
Bicyclic compounds as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders App 20060111360 - Guo; Tao ; et al.	2006-05-25
Aryl and biaryl compounds having MCH modulatory activity Grant 7,034,056 - Hobbs , et al. April 25, 2	2006-04-25
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20040209878 - Guzi, Timothy J. ; et al.	2004-10-21
Aryl and biaryl compounds having MCH modulatory activity App 20030092715 - Hobbs, Douglas Walsh ; et al.	2003-05-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.